Form 4: Biogen Director Acquires 1,340 Shares of Common Stock
SEC Form 4 Filing
Director Monish D Patolawala acquired 1,340 shares of Biogen Inc. common stock on June 21, 2024.
Summary
- On June 21, 2024, Monish D Patolawala, a director of Biogen Inc., acquired 1,340 shares of common stock.
- The shares were acquired directly.
- Following the transaction, Mr. Patolawala beneficially owns 1,340 shares of Biogen Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the transaction itself is neither overwhelmingly positive nor negative. It reflects a director's investment in the company, which can be interpreted as a neutral indicator.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors seeking insights into management's perspective on the company's valuation and future performance.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of transaction: Acquisition of 1,340 shares of Biogen Inc. common stock. |
| 06/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.